Activity of propyl-propane-thiosulfinate and propyl-propane-thiosulfonate against carbapenem-resistant Gram-negative bacteria.
Gram‐negative bacilli
antibacterial activity
carbapenemases
propyl‐propane‐thiosulfinate
propyl‐propane‐thiosulfonate
Journal
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ISSN: 1600-0463
Titre abrégé: APMIS
Pays: Denmark
ID NLM: 8803400
Informations de publication
Date de publication:
16 May 2024
16 May 2024
Historique:
received:
07
11
2023
accepted:
15
04
2024
medline:
17
5
2024
pubmed:
17
5
2024
entrez:
17
5
2024
Statut:
aheadofprint
Résumé
Organosulfur compounds derived from plants of the Allium genus, such as propyl-propane-thiosulfinate (PTS) and propyl-propane-thiosulfonate (PTSO), have been proposed as an alternative in antibiotic resistance. The aim of this study was to compare the activity of these substances with other antibiotics against clinical isolates of carbapenem-resistant (CAR-R) and carbapenem-susceptible (CAR-S) Gram-negative bacteria. A total of 126 clinical isolates of CAR-R and 155 CAR-S bacteria were selected, including Enterobacterales, A. baumannii and P. aeruginosa. The antibiotic susceptibility of all isolates was assessed using the microdilution and Kirby-Bauer methods for PTS, PTSO, amoxicillin/clavulanate, piperacillin/tazobactam, cefotaxime, ceftazidime, cefepime, imipenem, ciprofloxacin, and amikacin. Both PTS and PTSO demonstrated in vitro bactericidal activity against CAR-R Enterobacteriaceae and A. baumannii, with no significant difference in activity compared to their response against CAR-S isolates. However, both compounds were less active against P. aeruginosa than against any of the other bacteria, regardless of their resistance to carbapenems. In all cases, the minimum inhibitory concentration values of PTSO were significantly lower than those of PTS. These findings offer valuable information about the potential antibacterial use of these substances, particularly against infections that currently have limited therapeutic options.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Pathology, Medical Microbiology and Immunology.
Références
Mousavi SM, Babakhani S, Moradi L, Karami S, Shahbandeh M, Mirshekar M, et al. Bacteriophage as a novel therapeutic weapon for killing colistin‐resistant multi‐drug‐resistant and extensively drug‐resistant gram‐negative bacteria. Curr Microbiol. 2021;78:4023–4036.
Meng H, Han L, Niu M, Xu L, Xu M, An Q, et al. Risk factors for mortality and outcomes in hematological malignancy patients with carbapenem‐resistant Klebsiella pneumoniae bloodstream infections. Infect Drug Resist. 2022;15:4241–4251.
Montrucchio G, Costamagna A, Pierani T, Petitti A, Sales G, Pivetta E, et al. Bloodstream infections caused by carbapenem‐resistant pathogens in intensive care units: risk factors analysis and proposal of a prognostic score. Pathogens. 2022;11:718.
Sánchez‐García JM, Sorlózano‐Puerto A, Navarro‐Marí JM, Gutiérrez Fernández J. Evolution of the antibiotic‐resistance of microorganisms causing urinary tract infections: a 4‐year epidemiological surveillance study in a hospital population. Rev Clin Esp (Barc). 2019;219:116–123.
Garnacho‐Montero J, Amaya‐Villar R. The problem of multi‐resistance in gram‐negative bacilli in intensive care units: treatment and prevention strategies. Med Intensiva. 2022;46:326–335.
Hansen GT. Continuous evolution: perspective on the epidemiology of carbapenemase resistance among Enterobacterales and other gram‐negative bacteria. Infect Dis Ther. 2021;10:75–92.
Artero‐López J, Gutiérrez‐Soto B, Expósito‐Ruiz M, Sorlózano‐Puerto A, Navarro‐Marí JM, Gutiérrez‐Fernández J. Etiology of urinary tract infections in our health area and susceptibility profile of the most common uropathogens. Arch Esp Urol. 2021;74:197–207.
Moloney MG. Natural products as a source for novel antibiotics. Trends Pharmacol Sci. 2016;37:689–701.
Bhatia P, Sharma A, George AJ, Anvitha D, Kumar P, Dwivedi VP, et al. Antibacterial activity of medicinal plants against ESKAPE: an update. Heliyon. 2021;7:e06310.
Harris JC, Cottrell SL, Plummer S, Lloyd D. Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol. 2001;57:282–286.
Argüello‐García R, de la Vega‐Arnaud M, Loredo‐Rodríguez IJ, Mejía‐Corona AM, Melgarejo‐Trejo E, Espinoza‐Contreras EA, et al. Activity of thioallyl compounds from garlic against Giardia duodenalis trophozoites and in experimental giardiasis. Front Cell Infect Microbiol. 2018;8:353.
Tesfaye A. Revealing the therapeutic uses of garlic (Allium sativum) and its potential for drug discovery. ScientificWorldJournal. 2021;2021:8817288.
Guillamón E. Effect of phytochemical compounds of the genus Allium on the immune system and the inflammatory response. Ars Pharm. 2018;59:185–196.
Sorlozano‐Puerto A, Albertuz‐Crespo M, Lopez‐Machado I, Ariza‐Romero JJ, Banos‐Arjona A, Exposito‐Ruiz M, et al. In vitro antibacterial activity of propyl‐propane‐thiosulfinate and propyl‐propane‐thiosulfonate derived from Allium spp. against gram‐negative and gram‐positive multidrug‐resistant bacteria isolated from human samples. Biomed Res Int. 2018;2018:7861207.
Sorlozano‐Puerto A, Albertuz‐Crespo M, Lopez‐Machado I, Gil‐Martinez L, Ariza‐Romero JJ, Maroto‐Tello A, et al. Antibacterial and antifungal activity of propyl‐propane‐thiosulfinate and propyl‐propane‐thiosulfonate, two organosulfur compounds from Allium cepa: in vitro antimicrobial effect via the gas phase. Pharmaceuticals. 2021;14:21.
Savard P, Perl TM. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clin Microbiol Infect. 2014;20:854–861.
Brañas P, Gil M, Villa J, Orellana MA, Chaves F. Molecular epidemiology of carbapenemase‐producing Enterobacteriaceae infection/colonisation in a hospital in Madrid. Enferm Infecc Microbiol Clin. 2018;36:100–103.
Tórtola MT, Lavilla S, Miró E, González JJ, Larrosa N, Sabaté M, et al. First detection of a carbapenem‐hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain. Antimicrob Agents Chemother. 2005;49:3492–3494.
Argente M, Miró E, Martí C, Vilamala A, Alonso‐Tarrés C, Ballester F, et al. Molecular characterization of OXA‐48 carbapenemase‐producing Klebsiella pneumoniae strains after a carbapenem resistance increase in Catalonia. Enferm Infecc Microbiol Clin. 2019;37:82–88.
Oteo J, Saez D, Bautista V, Fernández‐Romero S, Hernández‐Molina JM, Pérez‐Vázquez M, et al. Carbapenemase‐producing enterobacteriaceae in Spain in 2012. Antimicrob Agents Chemother. 2013;57(2):6344–6347.
Rivera‐Izquierdo M, Láinez‐Ramos‐Bossini AJ, Rivera‐Izquierdo C, López‐Gómez J, Fernández‐Martínez NF, Redruello‐Guerrero P, et al. OXA‐48 carbapenemase‐producing Enterobacterales in spanish hospitals: an updated comprehensive review on a rising antimicrobial resistance. Antibiotics (Basel). 2021;10:89.
Cano‐Martín E, Portillo‐Calderón I, Pérez‐Palacios P, Navarro‐Marí JM, Fernández‐Sierra MA, Gutiérrez‐Fernández J. A study in a regional hospital of a mid‐sized spanish city indicates a major increase in infection/colonization by carbapenem‐resistant bacteria, coinciding with the COVID‐19 pandemic. Antibiotics (Basel). 2021;10:1127.
Boucher HW, Talbot GH, Benjamin DK Jr, Bradley J, Guidos RJ, Jones RN, et al. 10x '20 Progress‐development of new drugs active against gram‐negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:1685–1694.
Ruiz R, García MP, Lara A, Rubio LA. Garlic derivatives (PTS and PTS‐O) differently affect the ecology of swine faecal microbiota in vitro. Vet Microbiol. 2010;144:110–117.
Abad P, Lara FJ, Arroyo‐Manzanares N, Baños A, Guillamón E, García‐Campaña AM. High‐performance liquid chromatography method for the monitoring of the Allium derivative propyl propane thiosulfonate used as natural additive in animal feed. Food Anal Methods. 2015;8:916–921.
Peinado MJ, Ruiz R, Echávarri A, Aranda‐Olmedo I, Rubio LA. Garlic derivative PTS‐O modulates intestinal microbiota composition and improves digestibility in growing broiler chickens. Anim Feed Sci Technol. 2013;181:87–92.
Cabello‐Gómez JF, Aguinaga‐Casañas MA, Falcón‐Piñeiro A, González‐Gragera E, Márquez‐Martín R, Agraso M, et al. Antibacterial and antiparasitic activity of propyl‐propane‐thiosulfinate (PTS) and propyl‐propane‐thiosulfonate (PTSO) from Allium cepa against gilthead sea bream pathogens in in vitro and in vivo studies. Molecules (Basel). 2022;27:6900.
Miron T, Rabinkov A, Mirelman D, Wilchek M, Weiner L. The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim Biophys Acta. 2000;1463:20–30.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Vol Supp M100. 31st ed. Wayne, PA, USA: CLSI; 2021.
Cascajosa‐Lira A, Pichardo S, Baños A, Guillamón E, Molina‐Hernández V, Moyano R, et al. Acute and subchronic 90‐days toxicity assessment of propyl‐propane‐thiosulfinate (PTS) in rats. Food Chem Toxicol. 2022;161:112827.
Lira AC, Prieto AI, Baños A, Guillamón E, Moyano R, Jos A, et al. Safety assessment of propyl‐propane‐thiosulfonate (PTSO): 90‐days oral subchronic toxicity study in rats. Food Chem Toxicol. 2020;144:111612.
Sorlozano A, Jimenez‐Pacheco A, de Dios Luna Del Castillo J, Sampedro A, Martinez‐Brocal A, Miranda‐Casas C, et al. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7‐year surveillance study. Am J Infect Control. 2014;42:1033–1038.